|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/06 | |
| C07K 16/28 | |||
| A61K 39/395 | |||
| C12N 15/13 |
| (11) | Number of the document | 1478738 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03713632.2 |
| Date of filing the European patent application | 2003-02-21 | |
| (97) | Date of publication of the European application | 2004-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2008-11-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/005500 |
| Date | 2003-02-21 |
| (87) | Number | WO 2003/072766 |
| Date | 2003-09-04 |
| (30) | Number | Date | Country code |
| 81128 | 2002-02-22 | US |
| (72) |
OLSON, William, C., US
MADDON, Paul. J., US
VASQUEZ, Maximiliano, US
HINTON, Paul, R., US
TSURUSHITA, Naoya, US
|
| (73) |
PROGENICS PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
PDL BioPharma, Inc., 1400 Seaport Blvd., Redwood City, CA 94063, US |
| (54) | ANTI-CCR5 ANTIBODY |
| ANTI-CCR5 ANTIBODY |